IHH FutureHealth.Now 2026 explores affordability, AI and precision medicine

Regional leaders convened in Singapore to explore how innovation, partnerships and new care models can make healthcare more affordable, accessible and personalised.

 Ashok Pandit (Group Chief Corporate Officer at IHH Healthcare) giving his opening address during FutureHealth.Now 2026

Ashok Pandit (Group Chief Corporate Officer at IHH Healthcare) giving his opening address during FutureHealth.Now 2026

IHH Healthcare hosted the second edition of FutureHealth.Now, its flagship regional leadership conference, at The Ritz-Carlton, Millenia Singapore. Under the theme ‘Redefining the Care Stack’, the conference brought together more than 300 leaders from government, healthcare, technology, finance and investment to discuss how stronger partnerships across the healthcare ecosystem can better address evolving patient and healthcare ecosystem needs.

Against a backdrop of geopolitical uncertainty, supply chain disruptions and rapid advances in artificial intelligence (AI) and precision medicine, FutureHealth.Now provided a platform for industry leaders to explore how innovation, technology and new models of care can help tackle rising healthcare costs, workforce pressures and growing demand for services across the region.

At his opening address, Ashok Pandit, Group Chief Corporate Officer, IHH Healthcare, described the 'care stack' as the combination of people, technology, financing and policy that must work together to support high-quality care in an increasingly complex healthcare environment.

“Healthcare systems today are facing pressures like never before. Demand is rising faster than capacity, costs are increasing faster than affordability, and expectations are growing faster than our systems can adapt. The way we have delivered healthcare for the past 50 years will not be enough for the next 50. That is why we are redefining the care stack – bringing together people, science, technology, infrastructure, capital, policy and trust to reimagine how care is designed and delivered. Ultimately, our goal is simple – better outcomes, greater access and better value for patients,” he said.

Investing in the next decade of healthcare

The conference’s opening panel examined how healthcare can become a driver of productivity, economic growth and national competitiveness, and the role of investment, innovation and technology in building more sustainable health systems for the future.

Moderated by CNBC’s news anchor Christine Tan, the panel featured Dr Prem Kumar Nair, Group Chief Executive Officer, IHH Healthcare; Ganen Sarvananthan, Managing Partner, TPG Asia; and Associate Professor Daniel Ting, Co-Director, SingHealth Duke NUS AI Medicine Institute, Chief Data and Digital Officer.

When asked about what will shape investment decision in the next decade, Dr Prem shared, “Three healthcare megatrends that will reshape how care is delivered are ageing populations, the advancement of technologies including AI, robotics and imaging but most importantly, healthcare affordability.”

The programme featured senior voices from across the healthcare and investment landscape, including:

Local speakers based in Singapore included Jonathan Sugihara, Head of AI Success Engineering, OpenAI; Associate Professor Daniel Ting, Founding Co-Director, SingHealth Duke NUS AI Medicine Institute, Chief Data and Digital Officer; Fabio La Mola, Partner Singapore, Bain & Company; Professor Joseph Sung, Dean, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Dr Tan Min-Han, Founding Chief Executive Officer & Medical Director, Lucence; and Dr Zubin Daruwalla, Group Director Technology Innovation Office, National University Health System.

International speakers included Dr Indu Bhushan, Economist & Founding CEO, National Health Authority, India; Dr Khalid Fakhro, Chief Research Officer and Director of the Precision Medicine Programme, Sidra Medicine; Ganen Sarvananthan, Managing Partner, TPG Asia; Jennie Kung, Vice-Chair, Mayo Clinic Berg Innovation Exchange; Lawrence Lam, Chief Executive Officer, Prudential Hong Kong; and Mark Middleton OAM, Group Chief Executive Officer, ICON Group.

Throughout the day, key topics included how health systems can improve outcomes while remaining affordable. This highlights the need to accelerate value-based care, expand care beyond hospitals through community and virtual models, and strengthen public-private partnerships to improve access while ensuring long-term sustainability.

The conference also discussed how artificial intelligence is moving from experimentation to real-world implementation. Predictive analytics, workflow automation and digital tools are already improving operational efficiency, supporting clinical decision-making and enabling more personalised care. Speakers underscored that trust, governance and responsible adoption will be critical to scaling AI across healthcare.

Cancer care and precision medicine also emerged as key priorities for the future of healthcare. Experts discussed how rising cancer incidence and increasingly informed, digitally empowered patients are reshaping expectations of care, requiring more personalised and coordinated approaches. The conversation also explored how advances in genomics, biomarker-driven therapies and data-informed clinical decision-making are bringing precision medicine closer to routine clinical practice, alongside the partnerships, infrastructure and equitable access needed to scale these innovations sustainably.

IHH Healthcare Singapore launches Healthspan, expanding its focus on preventive health and longevity

Reflecting the conference’s focus on preventive and personalised healthcare, IHH Healthcare Singapore unveiled Healthspan, an initiative that supports individuals to live healthier and more fulfilling lives. Healthspan represents a shift from traditional episodic care to a proactive, continuous health management model centred on early detection, personalised interventions and long-term wellbeing.

As a broader philosophy of care, Healthspan will be supported through a range of current and future offerings across IHH Healthcare Singapore's network, including preventive screening, advanced diagnostics, genomic health, specialised services and targeted programmes. Bringing together clinical expertise, data-driven insights and multidisciplinary capabilities, it supports individuals across different life stages, helping them better understand future risks and take a more proactive approach to healthy ageing.

FutureHealth.Now 2026 builds on the inaugural edition of the conference held in Kuala Lumpur in August 2025, which convened more than 350 leaders and experts across healthcare, government and business. More information on FutureHealth.Now is available at www.ihhhealthcare.com/futurehealth-now.